Loading tape…Loading tape…
BSX
BSX
BSX
BSX NASDAQ
Following the report that Boston Scientific is up 1.5% since its last earnings release, the company's financial metrics reflect its current operational scale. Boston Scientific boasts a market capitalization of approximately $71.05 billion alongside an annual revenue of $20.07 billion. Additionally, the firm trades at a P/E ratio of 19.27 with a trailing twelve-month EPS of 2.48 and a free cash flow yield of 5.10%.
Based on zacks.comBoston Scientific (BSX) Up 1.5% Since Last Earnings Report: Can It Continue?
New Strong Sell Stocks for August 28th
Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall
Boston Scientific Stock Slides After Cyberattack Caused ‘Global Disruption'
Medical device maker Boston Scientific says a cyberattack is causing a ‘global disruption' to its operations
Boston Scientific Reports Global Disruption After Cybersecurity Incident
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.